Premier Value (bismuth subsalicylate) NDC 68016-124

NDC codes

FDA NDC Directory

Product NDC (as listed)68016-124Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68016-0124Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68016-124-30	68016012430	1 BOTTLE in 1 CARTON (68016-124-30) / 30 TABLET, CHEWABLE in 1 BOTTLEMarketed from May 22, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Premier Value
Generic name (nonproprietary): bismuth subsalicylate
Active ingredients: Bismuth subsalicylate — 262 mg/1
Dosage form: Tablet, Chewable
Route: Oral
Labeler: CHAIN DRUG CONSORTIUM,LLC
Product type: Over-the-counter drug
Marketing category: OTC monograph drugApplication M 008
Marketing start: May 22, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 68016-124_4e9bcd0e-072f-4094-b19a-7467afd047f7SPL ID 4e9bcd0e-072f-4094-b19a-7467afd047f7SPL set ID 3b8850e8-f9c2-4d52-aadd-8e037fabdee4RxCUI 308761UNII 62TEY51RR1

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468016012430 followed by a unit qualifier and the quantity

Package 68016-0124-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 28, 2024.

Indications (excerpt from the label)

Uses relieves: ▪ travelers’ diarrhea ▪ diarrhea ▪ upset stomach due to overindulgence in food and drink, including: ▪ heartburn ▪ indigestion ▪ nausea ▪ gas ▪ belching ▪ fullness

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)